diclofenac has been researched along with Immunoglobulin Light-chain Amyloidosis in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Immunoglobulin Light-chain Amyloidosis: A nonproliferative disorder of the PLASMA CELL characterized by excessive production and misfolding of IMMUNOGLOBULIN LIGHT CHAINS that form insoluble amyloid fibrils (see AMYLOID DEPOSITS) in various tissues. Clinical features include LIVER FAILURE; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; RESTRICTIVE CARDIOMYOPATHY, and neuropathies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandhok, S | 1 |
| Pereira, L | 1 |
| Momchilova, EA | 1 |
| Marijan, D | 1 |
| Zapf, R | 1 |
| Lacroix, E | 1 |
| Kaur, A | 1 |
| Keymanesh, S | 1 |
| Krieger, C | 1 |
| Audas, TE | 1 |
1 other study available for diclofenac and Immunoglobulin Light-chain Amyloidosis
| Article | Year |
|---|---|
Stress-mediated aggregation of disease-associated proteins in amyloid bodies.
Topics: Amyloidogenic Proteins; Amyloidosis; Diclofenac; Humans; Immunoglobulin Light-chain Amyloidosis; Pro | 2023 |